ampliatx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | Amplia Therapeutics |
| Description | Amplia Therapeutics Limited is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a |
| Keywords | Amplia Therapeutics Limited |
Server Information
| WebSite | |
| Host IP | 54.79.107.72 |
| Location | Australia |
Related Websites
| Site | Rank |
More to Explore
ampliatx.com Valuation
|
US$2,103,441
Last updated: 2023-05-03 21:23:12
ampliatx.com has Semrush global rank of 5,031,901. ampliatx.com has an estimated worth of US$ 2,103,441, based on its estimated Ads revenue. ampliatx.com receives approximately 242,705 unique visitors each day. Its web server is located in Australia, with IP address 54.79.107.72. According to SiteAdvisor, ampliatx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,103,441 |
| Daily Ads Revenue | US$1,942 |
| Monthly Ads Revenue | US$58,250 |
| Yearly Ads Revenue | US$698,990 |
| Daily Unique Visitors | 16,181 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ampliatx.com. | A | 86398 | IP: 54.79.107.72 |
| ampliatx.com. | NS | 86400 | NS Record: ns1.nameserver.net.au. |
| ampliatx.com. | NS | 86400 | NS Record: ns3.nameserver.net.au. |
| ampliatx.com. | NS | 86400 | NS Record: ns2.nameserver.net.au. |
| ampliatx.com. | MX | 86400 | MX Record: 10 mx1-us1.ppe-hosted.com. |
| ampliatx.com. | MX | 86400 | MX Record: 20 mx2-us1.ppe-hosted.com. |
| ampliatx.com. | TXT | 86400 | TXT Record: MS=ms62403313 |
| ampliatx.com. | TXT | 86400 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com include:spf.au.exclaimer.net mx -all |
HtmlToTextCheckTime:2023-05-03 21:23:12
| Menu Subscribe to our Email Alerts --> Home About Us Company Overview Our Values Board of Directors Team Scientific Advisers Clinical Advisers Corporate Directory Corporate Governance Pipeline Pipeline Cancer Program Fibrosis Program Clinical Trial Investor Information Welcome Investor Fact Sheet Investor Presentations Coverage Media Top 20 Shareholders Shareholder Services Investor FAQs US Shareholders Announcements and Reports ASX Announcements Publications Annual Reports Half Yearly Reports Quarterly Reports Research Reports Contact Us Contact Us Email Alerts Amplia Therapeutics Limited Focal Adhesion Kinase: A New Target in the Fight Against Cancer Learn more Amplia Therapeutics Limited Focus on Fibrotic Cancers and Fibrosis Learn more Amplia Therapeutics Limited Amplia’s ACCENT pancreatic cancer clinical trial is now recruiting Learn more A new approach for treating cancer and fibrotic diseases Amplia is a clinical-stage company developing small molecule inhibitors of Focal |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 141 Content-Type: text/html; charset=utf-8 Location: http://www.ampliatx.com/ Strict-Transport-Security: max-age=31536000 Date: Tue, 26 Oct 2021 01:29:35 GMT HTTP/1.1 302 Found Cache-Control: private Cache-control: no-cache="set-cookie" Content-Length: 131 Content-Type: text/html; charset=utf-8 Date: Tue, 26 Oct 2021 01:29:36 GMT Location: /site/content/ Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E465F080A728F3B5B668C02DDFEF36CD5A71C27E7A01616814D2D5248271BDE8AF0B06B7ECAAD740E2288EEE78DA66F8C697;PATH=/;MAX-AGE=600 Strict-Transport-Security: max-age=31536000 Connection: keep-alive HTTP/1.1 302 Found Cache-control: no-cache="set-cookie" Content-Length: 155 Content-Type: text/html; charset=utf-8 Date: Tue, 26 Oct 2021 01:29:36 GMT Location: https://www.ampliatx.com/site/content/ Set-Cookie: AWSELB=6513754B1C5CC94C36D4FA97FE6911DC2DDBF7E46578628D015A9121F2184A1C3FF9BF0642C27E7A01616814D2D5248271BDE8AF0BEC647D418D1169CD37248CA537D3FA62;PATH=/;MAX-AGE=600 Strict-Transport-Security: max-age=31536000 Connection: keep-alive HTTP/2 200 cache-control: private content-length: 33097 content-type: text/html; charset=utf-8 set-cookie: ASP.NET_SessionId=olzny4z1wj4qbzfo5nwuyzl4; path=/; secure; HttpOnly; SameSite=Lax strict-transport-security: max-age=31536000 date: Tue, 26 Oct 2021 01:29:37 GMT |
ampliatx.com Whois Information
Domain Name: AMPLIATX.COM Registry Domain ID: 2268620645_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.synergywholesale.com Registrar URL: http://https://synergywholesale.com Updated Date: 2021-01-27T23:25:26Z Creation Date: 2018-05-27T21:20:36Z Registry Expiry Date: 2023-05-27T21:20:36Z Registrar: Synergy Wholesale Pty Ltd Registrar IANA ID: 1609 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.NAMESERVER.NET.AU Name Server: NS2.NAMESERVER.NET.AU Name Server: NS3.NAMESERVER.NET.AU DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T03:08:07Z <<< |